abs427.txt	ras	genes	(hras		kras	and	nras)	comprise	the	most	frequently	mutated	oncogenefamily	in	human	cancer	with	highest	mutation	frequencies	seen	thetop	three	causes	of	deaths	united	states	(lung	colorectal	andpancreatic	cancer)	development	anti-ras	therapies	is	a	major	priority	forcancer	research	despite	more	than	decades	intense	effort	no	effectiveras	inhibitors	have	yet	to	reach	patient	bitter	lessons	learnedfrom	past	failures	new	ideas	strategies	there	renewed	hope	thatundruggable	may	finally	be	conquered	isoform	84%	ofall	ras-mutant	cancers	we	focus	on	near	100%	mutationfrequency	pancreatic	ductal	adenocarcinoma	(pdac)	considered	mostras-addicted	all	review	role	as	driver	andtherapeutic	target	pdac
